Quest Diagnostics Inc. (DGX) Financials
Key financial figures for Quest Diagnostics Inc. (Q2 2026).
Quest Diagnostics grew Q2 2026 revenue 10.2% to $3.04 billion on 13.1% requisition volume growth, and raised full-year 2026 revenue and EPS guidance. Revenue reached $3.04 billion, up 10.2% year over year (10.0% organic), with reported diluted EPS of $2.84 (+15.0%) and adjusted diluted EPS of $3.12 (+19.1%). Requisition (test) volume rose 13.1% year over year, almost entirely organic (13.0% organic requisition volume growth), while revenue per requisition declined 2.8%, indicating a mix shift toward lower-cost/higher-volume testing (consumer, wellness, and physician channels). Diagnostic Information Services revenue, the core reporting segment, rose 10.3% to $2.98 billion. On the outlook: Full year 2026 revenue raised to $11.95-$12.05 billion (from $11.78-$11.90 billion); reported diluted EPS raised to $9.97-$10.17 (from $9.58-$9.78); adjusted diluted EPS raised to $11.05-$11.25 (from $10.63-$10.83); cash provided by operations approximately $1.80 billion; capital expenditures approximately $550 million. Figures are for Q2 2026, as Quest Diagnostics Incorporated reported them.
- Revenue
- $3.0B
- Net Income
- $334M
- EPS
- $2.88
- Total Assets
- $16.9B
- Operating Cash Flow
- $597M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $3.0B | $320M | $2.84 | 15.08% | $330M |
| Q1 FY2026 | $2.9B | $252M | $2.24 | 13.78% | $164M |
| Q4 FY2025 | $2.8B | $245M | $2.18 | 13.93% | $307M |
| Q3 FY2025 | $2.8B | $245M | $2.16 | 13.71% | $419M |
| Q2 FY2025 | $2.8B | $282M | $2.47 | 15.86% | $436M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $11.0B | $992M | $8.75 | 14.53% | $1.4B |
| FY2024 | $9.9B | $871M | $7.69 | 13.63% | $909M |
| FY2023 | $9.3B | $854M | $7.52 | 13.64% | $864M |
Frequently asked questions
What was Quest Diagnostics Incorporated's revenue last quarter?
Quest Diagnostics Incorporated reported revenue of $3.04 billion for Q2 FY2026, up 10.2% from the same period a year earlier.
Is Quest Diagnostics Incorporated profitable?
Yes. Quest Diagnostics Incorporated reported net income of $320.0 million for Q2 FY2026, a net margin of 10.52% on revenue.
How has Quest Diagnostics Incorporated's margin trended?
Operating margin was 15.08% in Q2 FY2026, compared with 15.86% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does Quest Diagnostics Incorporated report next?
Quest Diagnostics Incorporated is scheduled to report results on 2026-10-20. The company has confirmed that date.
Full income statement, balance sheet and cash flow for Quest Diagnostics Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.